These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2968549)

  • 21. [Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].
    Merola B; Caruso E; De Chiara G; Rossi E; Longobardi S; Colao A; Brusco G; Lombardi G; Biraghi M
    Minerva Med; 1992 Dec; 83(12):805-13. PubMed ID: 1491760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DDAVP in the treatment of diabetes insipidus: a clinical study.
    Graham JJ; Wise PH; Harding PE
    Med J Aust; 1977 Jul; 2(4):113-6. PubMed ID: 895639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of vasopressin analogue DDAVP in patients with postoperative diabetes insipidus (author's transl)].
    Kubota T; Kashiwara K; Ito H; Tani K; Yamamoto S
    No To Shinkei; 1981 Jun; 33(3):617-23. PubMed ID: 7259900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of diabetes insipidus].
    Boscaro M; Mani E; Pistorello M; Rampazzo A
    Minerva Endocrinol; 1990; 15(1):95-9. PubMed ID: 2274021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral desmopressin treatment of central diabetes insipidus in children.
    Boulgourdjian EM; Martínez AS; Ropelato MG; Heinrich JJ; Bergadá C
    Acta Paediatr; 1997 Nov; 86(11):1261-2. PubMed ID: 9401525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diabetes insipidus: approaches to desmopressin substitution therapy].
    Thanh NC; Prokof'ev AB
    Klin Med (Mosk); 2011; 89(4):30-3. PubMed ID: 21932559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin)].
    Limal JM; Mugner E; Czernichow P
    Arch Fr Pediatr; 1977 Dec; 34(10):965-72. PubMed ID: 610662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
    Radó JP; Marosi J; Fischer J
    Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical use of DDAVP in a case of familial hypothalamo-pituitary diabetes insipidus].
    Filipponi P; Nicoletti I; Nunzi E; Benedetti Massi M; Santeusanio F
    Minerva Med; 1979 Jan; 70(4):347-56. PubMed ID: 431863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of central diabetes insipidus with DDAVP.
    Chiu WT; Shih CJ; Chen HY; Lin LS
    Taiwan Yi Xue Hui Za Zhi; 1985 Aug; 84(8):944-52. PubMed ID: 3865998
    [No Abstract]   [Full Text] [Related]  

  • 35. Sublingual administration of desmopressin. Effectiveness in an infant with holoprosencephaly and central diabetes insipidus.
    Kappy MS; Sonderer E
    Am J Dis Child; 1987 Jan; 141(1):84-5. PubMed ID: 3788888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of diabetes insipidus with DDAVP.
    Kikugawa CA; Cortopassi RF; Ditmer DG; Okamoto WS
    Am J Hosp Pharm; 1977 Sep; 34(9):1013-7. PubMed ID: 906988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of central diabetes insipidus with oral desmopressin in a premature neonate.
    Atasay B; Berberoğlu M; Günlemez A; Evliyaoğlu O; Adiyaman P; Unal S; Arsan S; Ocal G
    J Pediatr Endocrinol Metab; 2004 Feb; 17(2):227-30. PubMed ID: 15055359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Central diabetes insipidus in the very young child. Treatment with oral desmopressin].
    Fjellestad-Paulsen A; Crosnier H; Czernichow P
    Arch Fr Pediatr; 1988 Dec; 45(10):787-90. PubMed ID: 3071285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of central diabetes insipidus with a new synthetic preparation: DDAVP (1-deamino-8-D arginine vasopressin). Preliminary experience in 5 cases].
    Bernasconi S; Vanelli M; Giovannelli G
    Minerva Pediatr; 1975 Feb; 27(5):321-6. PubMed ID: 775282
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
    Tomita M; Nakagawa S; Saito N; Sakurada N; Nonoda A
    Horumon To Rinsho; 1979 Jun; 27(6):681-5. PubMed ID: 466837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.